Diffusion Pharmaceuticals Inc

NASDAQ:DFFN   12:53:09 PM EDT
8.45
+0.92 (+12.22%)
Other Pre-Announcement

Diffusion Says Co Has Sufficient Cash Resources To Fund Planned Trials Through 2023

Published: 09/09/2021 11:44 GMT
Diffusion Pharmaceuticals Inc (DFFN) - Diffusion Pharmaceuticals Issues Letter to Shareholders.
Diffusion Pharmaceuticals - Have Sufficient Cash Resources to Fund Planned Clinical Trials and Other Operational Needs Through 2023.